ad image

CMDO

1 / 1
Abzena
Bioconjugation

Abzena and Telix sign strategic manufacturing and bioconjugation agreement

Abzena

PR-M07-18-NI-016Jul 06, 2018
Bristol-Myers Squibb
Immuno-Oncology

European Commission Approves Bristol-Myers Squibb’s Yervoy (ipilimumab) for Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma

Bristol-Myers Squibb

PR-M01-18-NI-082Jan 25, 2018
Creating a Global C‘R’DMO for the Future of (Bio)pharma: Effective Strategies and Tactics
CRDMO

Creating a Global C‘R’DMO for the Future of (Bio)pharma: Effective Strategies and Tactics

Steven R. Hagen, Ph.D.; Dawn Von Rohr

Curia (formerly AMRI)

PAP-Q03-16-CL-001Aug 01, 2016
Quality by Design: Transforming 21st Century Pharmaceutical Manufacturing
QbD

Quality by Design: Transforming 21st Century Pharmaceutical Manufacturing

John Moscariello, Ph.D.

PAP-Q03-16-CL-003Aug 01, 2016
1 / 1